Atorvastatin Calcium
Product Images NDC 53808-1008

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53808-1008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 20mg (Atorvastatin 20mg)

Label Image For 20mg (Atorvastatin 20mg)
Atorvastatin Calcium 20 mg tablets label showing quantity of 30 tablets. The label includes prescription-only (Rx) designation, lot number C404553, and expiration date of 03-24-2015. Packaged by Florida DOH Central Pharmacy in Tallahassee, FL 32304. Barcode and UPC 355111122906 also visible.*
FDA Label Image

Label Image For 40mg (Atrovastatin 40mg)

Label Image For 40mg (Atrovastatin 40mg)
Atorvastatin Calcium 40 mg tablets packaging label showing quantity of 30 tablets. The label indicates prescription use only (RX Only), with batch and expiration information and states packaging by DOH Central Pharmacy, Tallahassee, FL. The UPC barcode is also visible.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph comparing the cumulative incidence (%) over a span of 3.5 years between Atorvastatin Calcium and placebo groups. The graph displays two lines, solid for Atorvastatin and dashed for placebo, with a lower incidence in the Atorvastatin group. Statistical data including hazard ratio and p-value are presented on the graph.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph comparing the cumulative hazard percentage over time (years) up to 5 years for Atorvastatin versus placebo. The solid line represents Atorvastatin, showing a lower cumulative hazard compared to the placebo's dashed line, with a hazard ratio and p-value noted on the graph.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A line graph showing the time to first major cardiovascular endpoint over 5 years for two doses of Atorvastatin Calcium, 10 mg and 80 mg. The x-axis represents time in years, and the y-axis represents the percentage of subjects experiencing an event. The graph includes a hazard ratio (HR) of 0.78 with a confidence interval and p-value of 0.0002.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of atorvastatin calcium showing the arrangement of functional groups and atoms within the molecule, including aromatic rings, hydroxyl groups, and the calcium ion complex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.